Spiess PE - Search Results

1

Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer.

Zargar H, Espiritu PN, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Gandhi NM, Griffin J, Montgomery JS, Vasdev N, Yu EY, Youssef D, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, Sridhar SS, McGrath JS, Aning J, Shariat SF, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Garcia JA, Stephenson AJ, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Black PC. Zargar H, et al. Among authors: spiess pe. Eur Urol. 2015 Feb;67(2):241-9. doi: 10.1016/j.eururo.2014.09.007. Epub 2014 Sep 23. Eur Urol. 2015. PMID: 25257030 Free PMC article.

2

Comparison of molecular and conventional strategies for followup of superficial bladder cancer using decision analysis.

Nam RK, Redelmeier DA, Spiess PE, Sampson HA, Fradet Y, Jewett MA. Nam RK, et al. Among authors: spiess pe. J Urol. 2000 Mar;163(3):752-7. J Urol. 2000. PMID: 10687970

3

Malignant mesothelioma of the tunica vaginalis.

Spiess PE, Tuziak T, Kassouf W, Grossman HB, Czerniak B. Spiess PE, et al. Urology. 2005 Aug;66(2):397-401. doi: 10.1016/j.urology.2005.03.012. Urology. 2005. PMID: 16040098

4

Metastatic umbilical mass from transitional cell carcinoma of the bladder.

Spiess PE, Kassouf W, Tukaram K, Roy I. Spiess PE, et al. Can J Urol. 2005 Oct;12(5):2856-8. Can J Urol. 2005. PMID: 16274525

5

Immediate versus staged urethrectomy in patients at high risk of urethral recurrence: is there a benefit to either approach?

Spiess PE, Kassouf W, Brown G, Highshaw R, Wang X, Do KA, Kamat AM, Czerniak B, Dinney CP, Grossman HB. Spiess PE, et al. Urology. 2006 Mar;67(3):466-71. doi: 10.1016/j.urology.2005.09.043. Urology. 2006. PMID: 16527559

6

Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy.

Blehm KN, Spiess PE, Bondaruk JE, Dujka ME, Villares GJ, Zhao YJ, Bogler O, Aldape KD, Grossman HB, Adam L, McConkey DJ, Czerniak BA, Dinney CP, Bar-Eli M. Blehm KN, et al. Among authors: spiess pe. Clin Cancer Res. 2006 Aug 1;12(15):4671-7. doi: 10.1158/1078-0432.CCR-06-0407. Clin Cancer Res. 2006. PMID: 16899617

7

Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen: can it be predicted using clinical parameters?

Spiess PE, Brown GA, Pisters LL, Liu P, Tu SM, Evans JG, Kamat AM, Black P, Tannir NM. Spiess PE, et al. Cancer. 2006 Oct 1;107(7):1503-10. doi: 10.1002/cncr.22181. Cancer. 2006. PMID: 16944534 Free article.

8

Chylous ascites after post-chemotherapy retroperitoneal lymph node dissection: review of the M. D. Anderson experience.

Evans JG, Spiess PE, Kamat AM, Wood CG, Hernandez M, Pettaway CA, Dinney CP, Pisters LL. Evans JG, et al. Among authors: spiess pe. J Urol. 2006 Oct;176(4 Pt 1):1463-7. doi: 10.1016/j.juro.2006.06.016. J Urol. 2006. PMID: 16952661

9

Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node dissection.

Spiess PE, Brown GA, Liu P, Tu SM, Tannir NM, Evans JG, Kamat AM, Kassouf W, Pisters LL. Spiess PE, et al. J Urol. 2007 Jan;177(1):131-8. doi: 10.1016/j.juro.2006.08.092. J Urol. 2007. PMID: 17162023

10

Review of the M.D. Anderson experience in the treatment of bladder sarcoma.

Spiess PE, Kassouf W, Steinberg JR, Tuziak T, Hernandez M, Tibbs RF, Czerniak B, Kamat AM, Dinney CP, Grossman HB. Spiess PE, et al. Urol Oncol. 2007 Jan-Feb;25(1):38-45. doi: 10.1016/j.urolonc.2006.02.003. Urol Oncol. 2007. PMID: 17208137

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

517 results

Search Page

Filters